Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Looking at radioiodine and other radio-labelled metabolites for thyroid cancers

2nd ecancer – TMC Kolkata Oncology Congress

30 Sep - 1 Oct 2023

Published: 9 Oct 2023

Views: 92

Rating:

Save

Dr Jayanta Das - Tata Medical Center, Kolkata, India

Dr Jayanta Das speaks at the 2nd ecancer TMC Oncology Congress, which was held at the Tata Medical Center, Kolkata, on 31 September and 1 October 2023.

Related Videos

Hormonal receptor positive breast cancer adjuvant and metastatic indications

Dr Aurelio Castrellon - Memorial Cancer Institute, Miami, USA

Hormonal receptor positive breast cancer adjuvant and metastatic indications ( Dr Aurelio Castrellon - Memorial Cancer Institute, Miami, USA )

ASCO 2024: Lung cancer highlights

Dr Antonio Passaro, Dr Matthew Krebs, Prof Raffaele Califano, Prof Nicolas Girard and Dr Anna Minchom

ASCO 2024: Lung cancer highlights ( Dr Antonio Passaro, Dr Matthew Krebs, Prof Raffaele Califano, Prof Nicolas Girard and Dr Anna Minchom )

Quality of life and patient satisfaction of Filipinos after breast conservation surgery and intraoperative radiotherapy

Dr Angeli Andrea Cocos-Alcantara - The Medical City, Pasig, Philippines

Quality of life and patient satisfaction of Filipinos after breast conservation surgery and intraoperative radiotherapy ( Dr Angeli Andrea Cocos-Alcantara - The Medical City, Pasig, Philippines )

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus

Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale Tomasini

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus ( Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale Tomasini )

Low-dose olanzapine after highly emetogenic chemotherapy can be the new standard of care for solid tumours

Dr Jyoti Bajpai - Tata Memorial Centre, Mumbai, India

Low-dose olanzapine after highly emetogenic chemotherapy can be the new standard of care for solid tumours ( Dr Jyoti Bajpai - Tata Memorial Centre, Mumbai, India )

Cabozantinib shows clinically meaningful improvement in advanced neuroendocrine tumours

Dr Jennifer Chan - Dana-Farber Cancer Institute, Boston, USA

Cabozantinib shows clinically meaningful improvement in advanced neuroendocrine tumours ( Dr Jennifer Chan - Dana-Farber Cancer Institute, Boston, USA )

Interpreting the results of a clinical trial

Dr Sanjit Agrawal, Tata Medical Center, Kolkata,India

Interpreting the results of a clinical trial ( Dr Sanjit Agrawal, Tata Medical Center, Kolkata,India )

Early breast cancer: Treatment pattern

Dr Soumen Das - Netaji Subhas Chandra Bose Cancer Hospital, Kolkata, India

Early breast cancer: Treatment pattern ( Dr Soumen Das - Netaji Subhas Chandra Bose Cancer Hospital, Kolkata, India )

Locally advanced breast cancer

Dr Rudradeep Banerjee - IPGMER and SSKM Hospital, Kolkata, India

Locally advanced breast cancer ( Dr Rudradeep Banerjee - IPGMER and SSKM Hospital, Kolkata, India )

More from ecancer